Gaponov, D.P.,
Khafizov, T.N.,
Kochkina, K.V.,
Chernov, I.I.,
Enginoev, S.T.,
Shaposhnikova, E.I. (2022) dissection (type I DeBakey — 30 cases (58,8%) and type III — 21 (41,2%)), 38 (43%) patients with aortic
Zhang, G.,
Zhu, Y.,
Ling, Y.,
Chen, P.,
Dai, J.,
Wang, Ch.,
Xu, Sh.,
Shumadalova, A.,
Shi, H. (2022) as modified treatment in cerebral ischemia (mTICI) 2b−
3 after endovascular therapy. Safety variables included
Bai, Ming,
Wang, Xiaolong,
Zhang, Huixue,
Wang, Jianjian,
Lyaysan, Gaysina,
Xu, Si,
Tian, Kuo,
Wang, Tianfeng,
Li, Jie,
Wang, Na,
Lu, Xiaoyu,
Zhang, Xiaoming,
Wang, Lihua (2022) , we
dissected the role of risk subclonal mutations in tumor evolution and found that advanced